跳至主要内容
临床试验/RBR-9ypbtf
RBR-9ypbtf已完成2 期

Study of safety and immunogenicity of the vaccine against human papillomavirus (HPV) in patients with Systemic Lupus Erythematosus (JSLE) and Juvenile Dermatomyositis (JMD)

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior0 个研究点开始时间: 2019年12月2日最近更新:
适应症

试验速览

研究概览

简要总结

暂无简介。

研究设计

研究类型
Intervention

入排标准

年龄范围
9Y 至 20Y(—)
性别
Female

入选标准

  • Being female; Be between 9-20 years old; Have been diagnosed with one of the following immune system disorders before the age of 17 and before their first quadrivalent vaccine against human papillomavirus: juvenile systemic lupus erythematosus or juvenile dermatomyositis; Have not received the three doses of the quadrivalent human papillomavirus vaccine

排除标准

  • The absence of parental consent for those under 18 or consent from the patient or control; refusal of any blood collection; hx of suspected or proven cervical carcinoma; being pregnant

研究者

相似试验